$BLPH Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Bellerophon Therapeutics, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Bellerophon Therapeutics, Inc.. Get notifications about new insider transactions in Bellerophon Therapeutics, Inc. for free.

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 26 2021	BLPH	Bellerophon Therap ...	Puissance Life Science Opportu ...	10% Owner	Option Exercise	A	18.63	304,286	5,668,848	685,236
Apr 26 2021	BLPH	Bellerophon Therap ...	Puissance Life Science Opportu ...	10% Owner	Option Exercise	A	12.00	380,950	4,571,400	380,950
Apr 26 2021	BLPH	Bellerophon Therap ...	Puissance Life Science Opportu ...	10% Owner	Grant	A	4.00	609,231	2,436,924	1,763,077	1.2 M to 1.8 M (+52.80 %)
Apr 02 2021	BLPH	Bellerophon Therap ...	Peacock Jonathan M		Grant	A	0.00	15,308	0	157,033	141.7 K to 157 K (+10.80 %)
Mar 22 2021	BLPH	Bellerophon Therap ...	New Mountain Investments II, L ...		Sell	S	5.48	400,000	2,192,000	609,231	1 M to 609.2 K (-39.63 %)
Mar 22 2021	BLPH	Bellerophon Therap ...	New Mountain Investments II, L ...		Sell	S	5.48	400,000	2,192,000	609,231	1 M to 609.2 K (-39.63 %)
Sep 14 2020	BLPH	Bellerophon Therap ...	FARES Wassim	Chief Medical Offic ...	Option Exercise	A	10.12	30,000	303,600	30,000
Sep 14 2020	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Option Exercise	A	10.12	6,509	65,871	13,806
Sep 14 2020	BLPH	Bellerophon Therap ...	Teufel Crispin	Director	Option Exercise	A	10.12	6,509	65,871	11,259
Sep 14 2020	BLPH	Bellerophon Therap ...	Moura Andre V.	Director	Option Exercise	A	10.12	6,509	65,871	13,472
Sep 14 2020	BLPH	Bellerophon Therap ...	BENNETT MATTHEW	Director	Option Exercise	A	10.12	6,509	65,871	6,509
Sep 14 2020	BLPH	Bellerophon Therap ...	Cloyd Mary Ann	Director	Option Exercise	A	10.12	6,509	65,871	14,472
Sep 14 2020	BLPH	Bellerophon Therap ...	Bruder Scott P	Director	Option Exercise	A	10.12	6,509	65,871	15,138
Sep 14 2020	BLPH	Bellerophon Therap ...	Amin Naseem	Director	Option Exercise	A	10.12	6,509	65,871	15,138
Sep 14 2020	BLPH	Bellerophon Therap ...	FARES Wassim	Chief Medical Offic ...	Buy	P	10.18	4,000	40,708	4,000	0 to 4 K
Jun 09 2020	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	12.87	2,600	33,454	60,913	58.3 K to 60.9 K (+4.46 %)
Jun 09 2020	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	12.72	4,986	63,442	58,313	53.3 K to 58.3 K (+9.35 %)
May 22 2020	BLPH	Bellerophon Therap ...	Puissance Life Science Opportu ...	10% Owner	Grant	A	13.00	1,153,846	14,999,998	1,153,846	0 to 1.2 M
Apr 20 2020	BLPH	Bellerophon Therap ...	Puissance Cross-Border Opportu ...	10% Owner	Sell	J	0.00	553,250	0	0	553.3 K to 0 (-100.00 %)
Jan 27 2020	BLPH	Bellerophon Therap ...	Peacock Jonathan M	Director	Grant	A	0.00	350,000	0	2,225,920	1.9 M to 2.2 M (+18.66 %)
Jan 27 2020	BLPH	Bellerophon Therap ...	Peacock Jonathan M	Director	Grant	A	0.00	350,000	0	2,225,920	1.9 M to 2.2 M (+18.66 %)
Nov 25 2019	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	0.39	7,193	2,774	592,922	585.7 K to 592.9 K (+1.23 %)
Nov 25 2019	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	0.37	1,050	394	585,729	584.7 K to 585.7 K (+0.18 %)
Nov 25 2019	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	0.37	200	74	584,679	584.5 K to 584.7 K (+0.03 %)
Nov 19 2019	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP of Business Oper ...	Payment of Exercise	F	0.34	25,993	8,838	105,606	131.6 K to 105.6 K (-19.75 %)
Nov 19 2019	BLPH	Bellerophon Therap ...	Fernandes Peter	Chief Regulatory & ...	Payment of Exercise	F	0.34	40,280	13,695	182,022	222.3 K to 182 K (-18.12 %)
Nov 19 2019	BLPH	Bellerophon Therap ...	Tenenbaum Fabian	Chief Executive Off ...	Payment of Exercise	F	0.34	76,823	26,120	407,459	484.3 K to 407.5 K (-15.86 %)
Nov 19 2019	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Payment of Exercise	F	0.34	27,134	9,226	124,619	151.8 K to 124.6 K (-17.88 %)
Nov 19 2019	BLPH	Bellerophon Therap ...	Korner Assaf	CFO	Payment of Exercise	F	0.34	32,987	11,216	66,078	99.1 K to 66.1 K (-33.30 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.44	333,010	146,091	6,435,173	6.8 M to 6.4 M (-4.92 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.45	56,242	25,511	6,768,183	6.8 M to 6.8 M (-0.82 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.50	704,595	353,354	6,824,425	7.5 M to 6.8 M (-9.36 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.44	333,010	146,091	6,435,173	6.8 M to 6.4 M (-4.92 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.45	56,242	25,511	6,768,183	6.8 M to 6.8 M (-0.82 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.50	704,595	353,354	6,824,425	7.5 M to 6.8 M (-9.36 %)
Sep 30 2019	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Option Exercise	A	0.50	46,266	23,133	109,482
Sep 30 2019	BLPH	Bellerophon Therap ...	Teufel Crispin	Director	Option Exercise	A	0.50	46,266	23,133	71,266
Sep 30 2019	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP Proj Mgmt & Dist ...	Option Exercise	A	0.50	175,500	87,750	445,854
Sep 30 2019	BLPH	Bellerophon Therap ...	Moura Andre V.	Director	Option Exercise	A	0.50	46,266	23,133	104,482
Sep 30 2019	BLPH	Bellerophon Therap ...	Fernandes Peter	Chief Regulatory & ...	Option Exercise	A	0.50	175,500	87,750	470,290
Sep 30 2019	BLPH	Bellerophon Therap ...	Tenenbaum Fabian	Chief Executive Off ...	Option Exercise	A	0.50	1,752,000	876,000	5,440,697
Sep 30 2019	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Option Exercise	A	0.50	175,500	87,750	438,483
Sep 30 2019	BLPH	Bellerophon Therap ...	Cloyd Mary Ann	Director	Option Exercise	A	0.50	46,266	23,133	119,482
Sep 30 2019	BLPH	Bellerophon Therap ...	Teufel Crispin	Director	Option Exercise	A	0.50	46,266	23,133	71,266
Sep 30 2019	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP Proj Mgmt & Dist ...	Option Exercise	A	0.50	175,500	87,750	445,854
Sep 30 2019	BLPH	Bellerophon Therap ...	Bruder Scott P	Director	Option Exercise	A	0.50	46,266	23,133	129,482
Sep 30 2019	BLPH	Bellerophon Therap ...	Moura Andre V.	Director	Option Exercise	A	0.50	46,266	23,133	104,482
Sep 30 2019	BLPH	Bellerophon Therap ...	Korner Assaf	CFO	Option Exercise	A	0.50	175,500	87,750	425,500
Sep 30 2019	BLPH	Bellerophon Therap ...	Fernandes Peter	Chief Regulatory & ...	Option Exercise	A	0.50	175,500	87,750	470,290
Sep 30 2019	BLPH	Bellerophon Therap ...	Tenenbaum Fabian	Chief Executive Off ...	Option Exercise	A	0.50	1,752,000	876,000	5,440,697
Sep 30 2019	BLPH	Bellerophon Therap ...	Amin Naseem	Director	Option Exercise	A	0.50	46,266	23,133	109,482
Sep 30 2019	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Option Exercise	A	0.50	175,500	87,750	438,483
Sep 30 2019	BLPH	Bellerophon Therap ...	Cloyd Mary Ann	Director	Option Exercise	A	0.50	46,266	23,133	119,482
Sep 30 2019	BLPH	Bellerophon Therap ...	BENNETT MATTHEW	Director	Option Exercise	A	0.50	46,266	23,133	84,482
Sep 30 2019	BLPH	Bellerophon Therap ...	Bruder Scott P	Director	Option Exercise	A	0.50	46,266	23,133	129,482
Sep 30 2019	BLPH	Bellerophon Therap ...	Korner Assaf	CFO	Option Exercise	A	0.50	175,500	87,750	425,500
Sep 30 2019	BLPH	Bellerophon Therap ...	Amin Naseem	Director	Option Exercise	A	0.50	46,266	23,133	109,482
Sep 30 2019	BLPH	Bellerophon Therap ...	BENNETT MATTHEW	Director	Option Exercise	A	0.50	46,266	23,133	84,482
Sep 30 2019	BLPH	Bellerophon Therap ...	Edmonds Amy	VP Clinical Operati ...	Option Exercise	A	0.50	175,500	87,750	445,886
Sep 30 2019	BLPH	Bellerophon Therap ...	Edmonds Amy	VP Clinical Operati ...	Option Exercise	A	0.50	175,500	87,750	445,886
Jun 14 2019	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	0.64	50,000	31,905	584,479	534.5 K to 584.5 K (+9.35 %)
Jun 14 2019	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	0.64	50,000	31,905	584,479	534.5 K to 584.5 K (+9.35 %)
Jun 10 2019	BLPH	Bellerophon Therap ...	Teufel Crispin	Director	Option Exercise	A	0.59	25,000	14,750	25,000
May 24 2019	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	0.60	27,500	16,533	534,479	507 K to 534.5 K (+5.42 %)
May 23 2019	BLPH	Bellerophon Therap ...	Edmonds Amy	VP Clinical Operati ...	Payment of Exercise	F	0.61	35,827	21,797	140,216	176 K to 140.2 K (-20.35 %)
May 22 2019	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	0.61	43,280	26,371	506,979	463.7 K to 507 K (+9.33 %)
May 22 2019	BLPH	Bellerophon Therap ...	Peacock Jonathan M	Director	Buy	P	0.61	20,000	12,198	1,875,920	1.9 M to 1.9 M (+1.08 %)
May 22 2019	BLPH	Bellerophon Therap ...	Tenenbaum Fabian	Chief Executive Off ...	Buy	P	0.60	5,000	2,975	484,282	479.3 K to 484.3 K (+1.04 %)
Mar 14 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.70	142,857	100,000	7,529,020	7.4 M to 7.5 M (+1.93 %)
Mar 14 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.70	142,857	100,000	7,529,020	7.4 M to 7.5 M (+1.93 %)
Jan 25 2019	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Buy	P	0.70	450,000	315,000	463,699	13.7 K to 463.7 K (+3,284.91 %)
Jan 25 2019	BLPH	Bellerophon Therap ...	Peacock Jonathan M	Director	Buy	P	0.70	714,286	500,000	1,855,920	1.1 M to 1.9 M (+62.57 %)
Jan 25 2019	BLPH	Bellerophon Therap ...	Peacock Jonathan M	Director	Grant	A	0.00	227,273	0	1,141,634	914.4 K to 1.1 M (+24.86 %)
Jan 25 2019	BLPH	Bellerophon Therap ...	Amin Naseem	Director	Buy	P	0.70	571,429	400,000	1,818,867	1.2 M to 1.8 M (+45.81 %)
Jan 04 2019	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP Proj Mgmt & Dist ...	Option Exercise	A	0.88	12,500	11,000	260,000
Jan 04 2019	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Option Exercise	A	0.88	12,500	11,000	262,983
Jan 04 2019	BLPH	Bellerophon Therap ...	Korner Assaf	CFO	Option Exercise	A	0.88	12,500	11,000	250,000
Nov 23 2018	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP Proj Mgmt & Dist ...	Option Exercise	A	0.91	137,500	125,125	247,500
Nov 23 2018	BLPH	Bellerophon Therap ...	Fernandes Peter	Chief Regulatory & ...	Option Exercise	A	0.91	137,500	125,125	282,290
Nov 23 2018	BLPH	Bellerophon Therap ...	Tenenbaum Fabian	Chief Executive Off ...	Option Exercise	A	0.91	1,487,500	1,353,625	3,676,197
Nov 23 2018	BLPH	Bellerophon Therap ...	Edmonds Amy	VP Clinical Operati ...	Option Exercise	A	0.91	137,500	125,125	257,886
Nov 23 2018	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Option Exercise	A	0.91	137,500	125,125	250,483
Nov 23 2018	BLPH	Bellerophon Therap ...	Korner Assaf	CFO	Option Exercise	A	0.91	137,500	125,125	237,500
Sep 27 2018	BLPH	Bellerophon Therap ...	Edmonds Amy	VP Clinical Operati ...	Grant	A	0.00	82,243	0	176,043	93.8 K to 176 K (+87.68 %)
Sep 27 2018	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Grant	A	0.00	82,243	0	151,753	69.5 K to 151.8 K (+118.32 %)
Sep 27 2018	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP Proj Mgmt & Dist ...	Grant	A	0.00	78,505	0	131,599	53.1 K to 131.6 K (+147.86 %)
Sep 27 2018	BLPH	Bellerophon Therap ...	Fernandes Peter	Chief Regulatory & ...	Grant	A	0.00	119,626	0	222,302	102.7 K to 222.3 K (+116.51 %)
Sep 27 2018	BLPH	Bellerophon Therap ...	Tenenbaum Fabian	Chief Executive Off ...	Grant	A	0.00	224,299	0	479,282	255 K to 479.3 K (+87.97 %)
Sep 27 2018	BLPH	Bellerophon Therap ...	Korner Assaf	CFO	Grant	A	0.00	99,065	0	99,065	0 to 99.1 K
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.18	60,000	70,944	7,386,163	7.3 M to 7.4 M (+0.82 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.23	75,000	92,250	7,326,163	7.3 M to 7.3 M (+1.03 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.19	75,000	89,160	7,251,163	7.2 M to 7.3 M (+1.05 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.18	60,000	70,944	7,386,163	7.3 M to 7.4 M (+0.82 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.23	75,000	92,250	7,326,163	7.3 M to 7.3 M (+1.03 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.19	75,000	89,160	7,251,163	7.2 M to 7.3 M (+1.05 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.15	75,000	85,913	7,176,163	7.1 M to 7.2 M (+1.06 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.14	200,000	228,840	7,101,163	6.9 M to 7.1 M (+2.90 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.22	200,000	243,640	6,901,163	6.7 M to 6.9 M (+2.98 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.15	75,000	85,913	7,176,163	7.1 M to 7.2 M (+1.06 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.14	200,000	228,840	7,101,163	6.9 M to 7.1 M (+2.90 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.22	200,000	243,640	6,901,163	6.7 M to 6.9 M (+2.98 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.90	60,000	53,742	6,701,163	6.6 M to 6.7 M (+0.90 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.84	50,000	42,095	6,641,163	6.6 M to 6.6 M (+0.76 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.85	50,000	42,325	6,591,163	6.5 M to 6.6 M (+0.76 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.90	60,000	53,742	6,701,163	6.6 M to 6.7 M (+0.90 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.84	50,000	42,095	6,641,163	6.6 M to 6.6 M (+0.76 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.85	50,000	42,325	6,591,163	6.5 M to 6.6 M (+0.76 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	66,393	43,109	6,541,163	6.5 M to 6.5 M (+1.03 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	272,000	175,902	6,474,770	6.2 M to 6.5 M (+4.39 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	190,977	123,868	6,202,770	6 M to 6.2 M (+3.18 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	66,393	43,109	6,541,163	6.5 M to 6.5 M (+1.03 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	272,000	175,902	6,474,770	6.2 M to 6.5 M (+4.39 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	190,977	123,868	6,202,770	6 M to 6.2 M (+3.18 %)
Jun 25 2018	BLPH	Bellerophon Therap ...	Moura Andre V.	Director	Grant	A	0.00	15,411	0	68,736	53.3 K to 68.7 K (+28.90 %)
Jun 25 2018	BLPH	Bellerophon Therap ...	Tasse Daniel	Director	Grant	A	0.00	11,987	0	182,604	170.6 K to 182.6 K (+7.03 %)
Jun 25 2018	BLPH	Bellerophon Therap ...	Luehring Jens	Director	Grant	A	0.00	14,555	0	95,213	80.7 K to 95.2 K (+18.05 %)
Jun 25 2018	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Grant	A	0.00	13,699	0	13,699	0 to 13.7 K
Jun 25 2018	BLPH	Bellerophon Therap ...	Amin Naseem	Director	Grant	A	0.00	17,124	0	1,247,438	1.2 M to 1.2 M (+1.39 %)
Jun 25 2018	BLPH	Bellerophon Therap ...	BENNETT MATTHEW	Director	Grant	A	0.00	11,987	0	30,552	18.6 K to 30.6 K (+64.57 %)
Jun 14 2018	BLPH	Bellerophon Therap ...	Quinn Deborah	Chief Medical Offic ...	Payment of Exercise	F	2.37	10,541	24,982	94,070	104.6 K to 94.1 K (-10.08 %)
Jun 14 2018	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP Proj Mgmt & Dist ...	Payment of Exercise	F	2.37	7,144	16,931	53,094	60.2 K to 53.1 K (-11.86 %)
Jun 14 2018	BLPH	Bellerophon Therap ...	Edmonds Amy	VP Clinical Operati ...	Payment of Exercise	F	2.37	7,499	17,773	93,800	101.3 K to 93.8 K (-7.40 %)
Jun 14 2018	BLPH	Bellerophon Therap ...	Tenenbaum Fabian	Chief Executive Off ...	Payment of Exercise	F	2.37	63,486	150,462	254,983	318.5 K to 255 K (-19.93 %)
Jun 14 2018	BLPH	Bellerophon Therap ...	Fernandes Peter	Chief Regulatory & ...	Payment of Exercise	F	2.37	11,304	26,790	102,676	114 K to 102.7 K (-9.92 %)
Jun 14 2018	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Payment of Exercise	F	2.37	7,473	17,711	69,510	77 K to 69.5 K (-9.71 %)
Jun 07 2018	BLPH	Bellerophon Therap ...	BENNETT MATTHEW	Director	Option Exercise	A	2.27	38,216	86,750	38,216
Jun 07 2018	BLPH	Bellerophon Therap ...	Tasse Daniel	Director	Option Exercise	A	2.27	38,216	86,750	58,216
Jun 07 2018	BLPH	Bellerophon Therap ...	Bruder Scott P	Director	Option Exercise	A	2.27	38,216	86,750	83,216
Jun 07 2018	BLPH	Bellerophon Therap ...	Moura Andre V.	Director	Option Exercise	A	2.27	38,216	86,750	58,216
Jun 07 2018	BLPH	Bellerophon Therap ...	Cloyd Mary Ann	Director	Option Exercise	A	2.27	38,216	86,750	73,216
Jun 07 2018	BLPH	Bellerophon Therap ...	Luehring Jens	Director	Option Exercise	A	2.27	38,216	86,750	58,216
Jun 07 2018	BLPH	Bellerophon Therap ...	Amin Naseem	Director	Option Exercise	A	2.27	38,216	86,750	83,216
Jun 07 2018	BLPH	Bellerophon Therap ...	Wang Theodore T	Director	Option Exercise	A	2.27	38,216	86,750	63,216
Apr 03 2018	BLPH	Bellerophon Therap ...	Peacock Jonathan M	Director	Grant	A	0.00	99,010	0	914,361	815.4 K to 914.4 K (+12.14 %)
Jan 17 2018	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Option Exercise	A	2.03	80,000	162,400	80,000
Jan 17 2018	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Grant	A	0.00	21,675	0	76,983	55.3 K to 77 K (+39.19 %)
Jan 17 2018	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP Proj Mgmt & Dist ...	Option Exercise	A	2.03	80,000	162,400	80,000
Jan 17 2018	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP Proj Mgmt & Dist ...	Grant	A	0.00	20,690	0	60,238	39.5 K to 60.2 K (+52.32 %)
Jan 17 2018	BLPH	Bellerophon Therap ...	Fernandes Peter	Chief Regulatory & ...	Option Exercise	A	2.03	100,000	203,000	100,000
Jan 17 2018	BLPH	Bellerophon Therap ...	Fernandes Peter	Chief Regulatory & ...	Grant	A	0.00	31,527	0	113,980	82.5 K to 114 K (+38.24 %)
Jan 17 2018	BLPH	Bellerophon Therap ...	Tenenbaum Fabian	Chief Executive Off ...	Option Exercise	A	2.03	550,000	1,116,500	550,000
Jan 17 2018	BLPH	Bellerophon Therap ...	Tenenbaum Fabian	Chief Executive Off ...	Grant	A	0.00	55,419	0	318,469	263.1 K to 318.5 K (+21.07 %)
Jan 17 2018	BLPH	Bellerophon Therap ...	Korner Assaf	CFO	Option Exercise	A	2.03	100,000	203,000	100,000
Jan 17 2018	BLPH	Bellerophon Therap ...	Quinn Deborah	Chief Medical Offic ...	Option Exercise	A	2.03	100,000	203,000	100,000
Jan 17 2018	BLPH	Bellerophon Therap ...	Quinn Deborah	Chief Medical Offic ...	Grant	A	0.00	29,557	0	104,611	75.1 K to 104.6 K (+39.38 %)
Jan 17 2018	BLPH	Bellerophon Therap ...	Edmonds Amy	VP Clinical Operati ...	Option Exercise	A	2.03	80,000	162,400	80,000
Jan 17 2018	BLPH	Bellerophon Therap ...	Edmonds Amy	VP Clinical Operati ...	Grant	A	0.00	21,675	0	101,299	79.6 K to 101.3 K (+27.22 %)
Jan 08 2018	BLPH	Bellerophon Therap ...	Fernandes Peter	Chief Regulatory & ...	Payment of Exercise	F	2.49	35,321	87,949	82,453	117.8 K to 82.5 K (-29.99 %)
Jan 08 2018	BLPH	Bellerophon Therap ...	Shah Parag Suresh	VP Proj Mgmt & Dist ...	Payment of Exercise	F	2.49	23,180	57,718	39,548	62.7 K to 39.5 K (-36.95 %)
Jan 08 2018	BLPH	Bellerophon Therap ...	Dekker Martin	VP of Engineering & ...	Payment of Exercise	F	2.49	24,284	60,467	55,308	79.6 K to 55.3 K (-30.51 %)

Page: 1 2 next >